Skip to evidence report

GRNLSA.p53_damage: Studies — page 2

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1,001–2,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
1001Phospholipids in large HDLGCST9049785312.38
1002Concentration of HDL particlesGCST9009282612.36
1003PM20D1 levelsGCST9047026812.36
1004Triglycerides in large VLDL (UKB data field 23501)GCST9026959812.36
1005Phosphatidylcholine diacyl C38:4 levelsGCST9024004612.35
1006Phospholipids in IDLGCST9049762612.34
1007EPHA4 levelsGCST9046913112.33
1008Cholelithiasis | digestiveUKBB0000013112.33
1009DTI TBSS L1 Anterior corona radiata RGCST9038445012.31
1010Free cholesterol in HDL (UKB data field 23422)GCST9026951912.30
1011C1RL levelsGCST9046849212.30
1012EVI5 levelsGCST9046915812.30
1013Triacylglycerol_56:7_[M+NH4]1+ levelsGCST9006055112.28
1014Red cell distribution widthGCST00680412.28
1015TDRKH levelsGCST9047082712.25
1016CDKN1A/FXN ratioGCST9031397112.25
1017FEN1 levelsGCST9046921312.23
1018Triglyceride levels in large LDLGCST9009286612.23
1019FN1 levelsGCST9046925512.20
1020Roast chicken likingGCST9009482112.20
1021X-21441 levelsGCST9020058112.20
1022Cholesterol to Total Lipids in Very Large HDL percentageGCST9050033312.19
1023IDP dMRI TBSS ICVF Posterior limb of internal capsule LGCST9000434612.19
1024PRDX5 levelsGCST9047031812.18
1025Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)GCST9026974012.17
1026Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivityGCST9030280412.15
1027Immature fraction of reticulocytesGCST00462812.15
1028IDP dMRI TBSS MO Retrolenticular part of internal capsule RGCST9000397212.14
1029ITGB5/SIAE ratioGCST9031523412.13
1030DAG1/MGLL ratioGCST9031437712.12
1031Omega-3 fatty acids to total fatty acids percentageGCST9050208812.11
1032Cholesterol esters in very small VLDLGCST9050074012.11
1033Degree of unsaturationGCST9050274912.11
1034IDP T1 FAST ROIs R putamenGCST9000255212.10
1035Cholesteryl Esters to Total Lipids in IDL percentageGCST9049753912.10
1036ITGB5/S100A4 ratioGCST9031523312.09
1037BA-exvivo rh area MTGCST9000323212.09
1038Total lipid levels in small HDLGCST9009295012.08
1039ALOX15B levelsGCST9061754712.04
1040Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)FING0000086612.04
1041Monounsaturated fatty acids levels (UKB data field 23447)GCST9026954412.04
1042Free cholesterol levels in medium HDLGCST9013267912.04
1043IDP dMRI TBSS ISOVF Corticospinal tract RGCST9000448312.03
1044Central corneal thicknessGCST00636612.02
1045NUDT5 levelsGCST9047010712.02
1046Triglycerides in VLDL (UKB data field 23408)GCST9026950512.02
1047Triglycerides to total lipids ratio in small VLDLGCST9009297912.00
1048Total lipids in IDLGCST9049760112.00
1049PCDH17/TEK ratioGCST9031560611.99
1050CASP8/SEPTIN9 ratioGCST9031365811.98
1051IDP dMRI ProbtrackX ICVF cst lGCST9000438311.96
1052XG levelsGCST9047108211.94
1053Triglycerides to total lipids ratio in very small VLDLGCST9009303911.92
1054ICA1/TANK ratioGCST9031511211.92
1055Cholesterol to total lipids ratio in very small VLDLGCST9009302911.91
1056Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST9050215311.90
1057Total lipid levels in chylomicrons and extremely large VLDLGCST9050099411.89
1058Alanine levelsGCST00366611.89
1059Methionine sulfone levelsGCST9019996111.89
1060Phospholipids to Total Lipids in IDL percentageGCST9049764411.84
1061T1 FreeSurfer aseg Left-Inf-Lat-VentGCST9038414011.84
1062Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T413ECGU00041311.83
1063BA-exvivo lh thickness BA4pGCST9000351811.82
1064F9 levelsGCST9046917211.81
1065Free Cholesterol to Total Lipids in IDL percentageGCST9049757611.81
1066MDK levelsGCST9046987711.81
1067Total triglycerides levels (UKB data field 23407)GCST9026950411.81
1068ITGB1 levelsGCST9046964311.81
1069NOTCH1 levelsGCST9047006511.80
1070SIRT2/STAT5B ratioGCST9031584611.80
1071Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST9030271511.79
1072T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124)GCST9032094311.79
1073Disorders of lipoprotein metabolism and other lipidaemiasFING0000044211.78
1074Total fatty acid levelsGCST9050221811.78
1075Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARBUKBB0000069011.78
1076Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616)GCST9026971311.77
1077CNTNAP2/DPP10 ratioGCST9031416711.77
1078Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T13ECGA00001311.77
1079Total fatty acid levelsGCST9050221111.76
1080SNCG levelsGCST9047069511.74
1081N-acetylmethionine levelsGCST9020028911.74
1082Concentration of very small VLDL particlesGCST9050081911.73
1083Phosphatidylcholine levelsGCST9049924811.73
1084GMPR2 levelsGCST9046936711.71
1085IDP dMRI TBSS L2 Anterior limb of internal capsule RGCST9000413911.71
1086Free Cholesterol to Total Lipids in Small HDL percentageGCST9049943111.69
1087Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T141ECGA00014111.66
1088CA4/TNFSF12 ratioGCST9031358911.65
1089AmygNuclei rh volume Paralaminar-nucleusGCST9000266611.65
1090Phospholipids to Total Lipids in Small HDL percentageGCST9049949411.64
1091HSD17B14 levelsGCST9046948311.64
1092Concentration of chylomicrons and extremely large VLDL particlesGCST9050101011.63
1093Diacylglycerol_44:7_[M+H-H2O]1+ levelsGCST9006024011.62
1094LYPD3 levelsGCST9046982811.60
1095NeuroticismGCST00523211.59
1096CXCL1 levelsGCST9001201911.59
1097Sphingomyelin_34:1_[M+H]1+ levelsGCST9006023911.56
1098IL4R levelsGCST9046959811.54
1099Left-hemisphere dorsal attention network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST9030269011.52
1100FST/FSTL3 ratioGCST9031488211.51
1101Degree of unsaturationGCST9050016211.51
1102METAP2 levelsGCST9046989411.51
1103Cholesterol in Medium HDLGCST9049849511.51
1104LGALS8/SOD2 ratioGCST9031532011.46
1105EREG/HBEGF ratioGCST9031470211.43
1106IL18BP/ROR1 ratioGCST9031515511.42
1107Irritable moodGCST00694111.39
1108Omega-3 fatty acids to total fatty acids percentageGCST9050245011.37
1109CD84/SEMA4D ratioGCST9031391711.33
1110TXNRD1 levelsGCST9047099411.33
1111GALNT10/SEMA7A ratioGCST9031491511.33
1112CANT1/ROR1 ratioGCST9031362011.32
1113Own or rent accommodation lived in - Own outright (by you or someone in your household) | HouseholdUKBB0000062311.30
1114APP/HBEGF ratioGCST9031332411.28
1115CPM/LAMP2 ratioGCST9031421511.26
1116ITGA5/LILRA2 ratioGCST9031520411.24
1117DNAJB1/EIF4B ratioGCST9031450811.23
1118Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST9026953211.22
1119Other diseases of liverFING0000100411.21
1120Omega-6 fatty acids to total fatty acids percentageGCST9050254411.21
1121Cholesteryl esters to total lipids ratio in small LDLGCST9009295911.20
1122Triglycerides in medium HDLGCST9049867211.20
1123Cholesteryl esters in medium HDL (UKB data field 23569)GCST9026966611.19
1124Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9ECGA00000911.18
1125KDR/VWF ratioGCST9031524511.18
1126TYRO3 levelsGCST9047099711.16
1127Cholesteryl esters in small VLDL (UKB data field 23513)GCST9026961011.15
1128WFDC1 levelsGCST9047107411.14
1129Total lipids in very large VLDL (UKB data field 23489)GCST9026958611.13
1130COL6A3/CST3 ratioGCST9031417411.13
1131Acylcarnitine (18:2) levelsGCST9002462311.11
1132SCLY/SORD ratioGCST9031581611.11
1133Takes medication for congestive heart failure?GCST9047520111.10
1134Free cholesterol to total lipids ratio in large LDLGCST9009286111.09
1135Congenital malformations of genital organsFING0000033311.05
1136NCR3LG1 levelsGCST9047001011.04
1137DTI TBSS L3 Sagittal stratum LGCST9038455511.03
1138SF3B4 levelsGCST9047060911.03
1139Operation code - spinal laminectomy | OperationsUKBB0000056411.02
1140Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050104511.02
1141IDP dMRI TBSS FA Superior cerebellar peduncle LGCST9000389011.00
1142Dihomo-linoleoylcarnitine (C20:2) levelsGCST9020014410.99
1143Triglycerides to Total Lipids in Medium LDL percentageGCST9049888510.98
1144IL18R1 levelsGCST9024160710.97
1145aseg lh intensity Lateral-VentricleGCST9000376410.97
1146OSCAR/TNFRSF14 ratioGCST9031558810.96
1147X-14626 levelsGCST9024386110.96
1148BA-exvivo lh thickness BA3bGCST9000351610.95
1149MPI levelsGCST9046993610.95
1150Triglycerides in large HDLGCST9049788210.95
1151Ratio of monounsaturated fatty acids to total fatty acidsGCST9009292910.94
1152HematocritGCST9027863410.94
1153Plasma cystathionine levels in chronic kidney diseaseGCST9026497410.94
1154Plasma 4-guanidinobutanoate levels in chronic kidney diseaseGCST9026462010.92
1155Type 2 diabetesGCST9008607210.91
1156HippSubfield lh volume Whole-hippocampal-headGCST9000268810.88
1157Triglyceride to phosphoglyceride ratioGCST9049999610.88
1158High myopiaGCST00996210.88
1159Saturated fatty acids levelsGCST9050265910.87
1160Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T108ECGA00010810.86
1161BLMH/PEAR1 ratioGCST9031351910.84
1162CD74/TNFRSF21 ratioGCST9031389710.84
1163Atherosclerosis, excluding cerebral and coronary sclerosisFING0000012310.84
1164CDKN1A/TBL1X ratioGCST9031397710.83
1165SEC31A levelsGCST9047056310.82
1166Triglycerides to Total Lipids in Medium HDL percentageGCST9049868910.82
1167Father's age | Family historyUKBB0000024010.82
1168DTI TBSS MD Anterior corona radiata LGCST9038459510.82
1169ACY1/GSTA1 ratioGCST9031316310.80
1170FST levelsGCST9046927310.79
1171FOLR2/THY1 ratioGCST9031486710.78
1172HDL cholesterol levels (UKB data field 23406)GCST9026950310.78
1173GALNT2 levelsGCST9046929610.78
1174Triglycerides in medium HDL (UKB data field 23571)GCST9026966810.78
1175CLEC1B/VSIR ratioGCST9031410610.73
1176ENO2 levelsGCST9046911010.72
1177PDGFRA levelsGCST9047019110.70
1178Total triglycerides levelsGCST00366410.69
1179CEACAM8/VNN2 ratioGCST9031400510.69
1180Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404ECGU00040410.68
1181Ever worried more than most people would in similar situation | AnxietyUKBB0000022710.67
1182Degree of unsaturationGCST9050273710.67
1183aseg rh volume PallidumGCST9000264010.66
1184CXCL6 levelsGCST9046893310.66
1185Medication for pain relief, constipation, heartburn - Paracetamol | MedicationUKBB0000045910.66
1186DTI TBSS L3 Posterior corona radiata LGCST9038455110.65
1187DTI autoptx MD ilf l tractGCST9038523410.65
1188Triglyceride levelsGCST9023966310.64
1189BA-exvivo rh area BA3bGCST9000322410.63
1190Cholesterol to total lipids ratio in large LDLGCST9009285710.63
1191Mean corpuscular hemoglobin varianceGCST9056569310.63
1192Linoleic acid levelsGCST9050201010.62
1193Mean corpuscular haemoglobin concentration | Blood countUKBB0000044810.60
1194NGRN levelsGCST9047004510.60
1195DTI autoptx L3 ilf l tractGCST9038520710.60
1196APOB/APOA1 ratioGCST9049715810.59
1197Polyunsaturated fatty acid levelsGCST9050262210.58
1198Fasting blood glucoseGCST00518610.58
1199DNMBP/TBC1D5 ratioGCST9031451910.57
1200Diabetes type 2 with peripheral circulatory (PheCode 250.25)GCST9047567810.57
1201Cholesteryl esters in HDL (UKB data field 23418)GCST9026951510.56
1202Polyunsaturated fatty acid levelsGCST9050261810.55
1203Triglycerides to Total Lipids in Very Large HDL percentageGCST9050050810.55
1204CD58 levelsGCST9046863810.53
1205BCAM/ICAM4 ratioGCST9031347210.53
1206SH2B3/TBL1X ratioGCST9031584110.52
1207ITGA2 levelsGCST9046963410.50
1208CHRDL2 levelsGCST9046875110.49
1209aseg lh volume PallidumGCST9000262310.49
1210Glycoprotein acetyls levels (UKB data field 23480)GCST9026957710.48
1211aparc-DKTatlas lh volume precentralGCST9000288410.48
1212HTRA2/SNAP29 ratioGCST9031509810.45
1213ASGR1/DCBLD2 ratioGCST9031336410.45
1214Cholesterol levels in medium HDLGCST9009289210.44
1215Triglyceride levels in very small VLDLGCST9009303810.43
1216CTRB1/PLA2G1B ratioGCST9031430710.43
1217CLMP levelsGCST9046878310.43
1218Raynaud's syndromeGCST9044818710.43
1219IDP dMRI ProbtrackX MD cst rGCST9000422810.42
1220CLUL1 levelsGCST9046879210.41
1221CD34 levelsGCST9046862610.40
1222LYN levelsGCST9046982610.40
1223PNMA1 levelsGCST9047027610.39
1224IL3RA levelsGCST9046959610.38
1225Monounsaturated fatty acids to total fatty acids percentageGCST9050237210.37
1226DTI autoptx L2 fmi tractGCST9038517710.37
1227Phospholipids to total lipids in small LDL percentage (UKB data field 23624)GCST9026972110.37
1228Chronic obstructive pulmonary diseaseGCST9001858710.36
1229IL22 levelsGCST9008806610.36
1230HGF/PLAUR ratioGCST9031505910.35
1231Microvirga abundance in stoolGCST9003247910.35
1232GALNT10 levelsGCST9046929510.33
1233Red cell distribution widthGCST9000240410.32
1234DTI autoptx MD ilf r tractGCST9038523510.31
1235T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128)GCST9032094710.31
1236Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST9050099210.31
1237Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T23ECGA00002310.30
1238ANGPTL2 levelsGCST9046830310.29
1239HGF levelsGCST9046944910.27
1240Saturated fatty acids levels (UKB data field 23448)GCST9026954510.26
1241ITPA levelsGCST9046965410.25
1242X-12100--hydroxytryptophan levelsGCST9024370210.24
1243Benign neoplasm: Adrenal glandFING0000016410.22
1244CTRL levelsGCST9046890710.22
1245SERPINB9 levelsGCST9047059310.20
1246SUSD1/THPO ratioGCST9031589910.19
1247Cholesterol in Medium HDLGCST9049849210.18
1248Cholesteryl ester levels in medium HDLGCST9009289410.18
1249Cholesteryl Esters in Medium HDLGCST9049853810.18
1250Cholesteryl ester_16:0_[M+NH4]1+ levelsGCST9006021110.16
1251aparc-Desikan lh thickness paracentralGCST9000346110.14
1252C1QTNF1/COL4A1 ratioGCST9031355210.14
1253Resting heart rateGCST9027863610.13
1254Concentration of chylomicrons and extremely large VLDL particlesGCST9050101510.13
1255Cholesterol in small HDL (UKB data field 23575)GCST9026967210.12
1256BSG/PCDH1 ratioGCST9031353510.12
1257MASP1 levelsGCST9046986310.11
1258HDL cholesterol levelsGCST9009282210.10
1259Phospholipids in small LDLGCST9049967310.10
1260IDP dMRI TBSS ICVF Splenium of corpus callosumGCST9000433110.10
1261Triglycerides to Total Lipids in Small HDL percentageGCST9049954310.09
1262Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10ECGA00001010.08
1263CHMP6 levelsGCST9046874710.07
1264F-whole food liking (derived food-liking factor)GCST9009486810.07
1265Cholesterol in Small LDLGCST9049955510.06
1266CFB levelsGCST9046872310.06
1267LRPAP1 levelsGCST9046980010.05
1268Free cholesterol in very small VLDLGCST9050077710.05
1269Leisure/social activities - None of the above | Social supportUKBB0000039910.05
1270CELA3A/PLA2G1B ratioGCST9031401410.05
1271METAP2/PFKFB2 ratioGCST9031543110.04
1272IDP dMRI TBSS L3 Uncinate fasciculus LGCST9000421610.02
1273Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86ECGU00008610.02
1274Omega-6 fatty acids to total fatty acids percentageGCST9050254110.02
1275CD226 levelsGCST9046860910.02
1276RSPO1/SFRP1 ratioGCST9031579110.01
1277DTI autoptx L1 ilf r tractGCST9038515410.01
1278PDGF-BB levelsGCST9042843010.00
1279Triglyceride levels in IDLGCST900928419.99
1280Triglycerides in small HDLGCST904995169.94
1281Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998049.93
1282Triglycerides to Total Lipids in Small VLDL percentageGCST904999349.92
1283RBKS levelsGCST904704339.90
1284Triglycerides in small HDLGCST904995199.90
1285PTPN6/YES1 ratioGCST903157509.90
1286FOXO3/MAP3K5 ratioGCST903148809.88
1287Total esterified cholesterol levelsGCST905000349.88
1288CRELD2 levelsGCST904688599.88
1289PTPRM levelsGCST904703849.87
1290Polyunsaturated fatty acids to total fatty acids percentageGCST905026459.87
1291IDP dMRI TBSS L1 Cerebral peduncle LGCST900040909.86
1292Polyp of the female genital tractFING000011909.86
1293Cholesterol in Large LDLGCST904979199.85
1294Triglyceride levels in large HDLGCST900928549.84
1295Omega-3 fatty acids to total fatty acids percentageGCST905020829.84
1296Triglycerides in HDLGCST904974649.84
1297Frailty (Factor 2 - Unhealthy Lifestyle)GCST906240489.82
1298IGFBP6/PTGDS ratioGCST903151379.81
1299Concentration of small HDL particles (UKB data field 23572)GCST902696699.81
1300Benign neoplasm of eye (PheCode 224)GCST904756269.81
1301Triglyceride levels in large VLDLGCST900928789.81
1302Omega-6 fatty acids to total fatty acids percentageGCST905021299.81
1303CSF1/IFNGR1 ratioGCST903142839.80
1304LTBR/TNFRSF14 ratioGCST903153409.80
1305Low density lipoprotein cholesterol levelsGCST902396579.80
1306HippSubfield rh volume GC-ML-DG-bodyGCST900027039.79
1307Phosphoglycerides levels (UKB data field 23434)GCST902695319.77
1308FSTL1 levelsGCST904692719.76
1309CELA3A/CTRB1 ratioGCST903140119.76
1310FAM177A1 levelsGCST902424589.75
1311FGFBP2 levelsGCST904692319.75
1312LDLR/MEGF9 ratioGCST903153109.72
1313PODXL2/SCG3 ratioGCST903157009.72
1314Financial situation satisfaction | Mental healthUKBB000002499.72
1315Sphingomyelin_40:3_[M+H]1+ levelsGCST900603489.71
1316MICB or MICA levelsGCST904699059.71
1317CDCP1/IL18BP ratioGCST903139379.70
1318GM3 ganglioside (d18:1/24:0) levelsGCST900247299.70
1319Phospholipids in very small VLDL (UKB data field 23518)GCST902696159.70
1320HS1BP3 levelsGCST904694779.70
13211-(1-enyl-stearoyl)-GPE (p-18:0) levelsGCST901999109.67
1322CASP8 levelsGCST904685489.67
1323Omega-3 fatty acids to total fatty acids percentageGCST905024519.66
1324CD300LG/CD93 ratioGCST903138009.66
1325PLA2G7 levelsGCST904702499.66
1326Sphingomyelin_34:0_[M+H]1+ levelsGCST900602419.66
1327CACNA2D3 levelsGCST902433489.64
1328CD22/FOLR2 ratioGCST903137589.62
1329CEACAM8/RNASE3 ratioGCST903140049.61
1330Concentration of small HDL particlesGCST904994619.61
1331CASP10 levelsGCST904685429.61
1332Free cholesterol to total lipids in IDL percentage (UKB data field 23612)GCST902697099.60
1333Sphingomyelin_42:2_[M+H]1+ levelsGCST900604039.59
1334ESAM/SCARF1 ratioGCST903147159.59
1335Phospholipids in very large VLDLGCST905006479.59
1336SH3GLB2 levelsGCST904706219.58
1337IDP dMRI TBSS L3 External capsule RGCST900042039.56
1338IGFBP7 levelsGCST904695329.55
1339Total concentration of lipoprotein particlesGCST900929909.55
1340BST1 levelsGCST904684749.55
1341RAB11FIP3 levelsGCST904704049.53
1342SNCA levelsGCST904706949.53
1343ICOSLG levelsGCST904695039.53
1344Phosphoglycerides levelsGCST900929389.52
1345LY6D/PLA2G10 ratioGCST903153459.52
13463-hydroxybutyrate levels (UKB data field 23474)GCST902695719.52
1347rfMRI connectivity (ICA100 edge 1090)GCST900059439.51
1348Sphingomyelin_36:1_[M+H]1+ levelsGCST900602669.49
1349CLEC1A/CLEC7A ratioGCST903140839.49
1350Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327ECGU0003279.49
1351Cholesteryl Esters in Medium HDLGCST904985329.49
1352Pregnenetriol disulfate levelsGCST902002389.48
1353SDC4/SERPINE1 ratioGCST903158199.47
1354Triglycerides to total lipids in large HDL percentage (UKB data field 23638)GCST902697359.47
1355SELE levelsGCST904705669.47
1356CD99L2/CPM ratioGCST903139259.46
1357Mean corpuscular hemoglobin concentrationGCST900023919.46
1358Cholesteryl esters in very large VLDL (UKB data field 23492)GCST902695899.46
1359Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24ECGA0000249.45
1360TINAGL1 levelsGCST904708739.44
1361HEXIM1/TRIAP1 ratioGCST903150549.44
1362NCAN levelsGCST904700059.44
1363aparc-a2009s rh area S-oc-middle+LunatusGCST900034279.44
1364HS6ST1/MEGF9 ratioGCST903150819.44
1365Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007989.43
1366Irritable bowel syndromeGCST900165649.43
1367Succinylcarnitine levelsGCST902438749.43
1368EIF4G1/TBC1D23 ratioGCST903146399.43
1369Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009299.42
1370Total lipids in very large VLDLGCST905006079.42
1371F11R/PLXNA4 ratioGCST903147249.42
1372Sphingomyelins levelsGCST904999729.41
1373Cholesteryl Esters in Medium LDLGCST904987389.41
1374Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140ECGA0001409.41
1375Triglycerides in VLDLGCST905002959.39
1376PRUNE2 levelsGCST904703499.39
1377CST3/IGFBP6 ratioGCST903142939.37
1378Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603269.37
1379KHK levelsGCST904696759.36
1380Concentration of very large HDL particles (UKB data field 23551)GCST902696489.35
1381Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T134ECGA0001349.35
1382Carotid artery plaque burdenGCST905030769.35
1383LAMA4 levelsGCST904697319.34
1384Sphingomyelin_38:2_[M+H]1+ levelsGCST900603029.33
1385Calcium levelsGCST900259909.33
1386Concentration of IDL particlesGCST904976149.32
1387Monounsaturated fatty acid levelsGCST905020369.31
1388FABP5 levelsGCST904691779.31
1389GSTA1/SULT2A1 ratioGCST903149969.31
1390FURIN/INHBC ratioGCST903148869.30
1391PLA2G4A/SNAP29 ratioGCST903156699.30
1392Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003399.30
1393Cholesteryl ester levels in small VLDLGCST900929709.30
1394Saturated fatty acids levelsGCST905026749.30
1395LAP3 levelsGCST904697379.28
1396IDP dMRI TBSS L1 Posterior limb of internal capsule LGCST900040949.28
1397Total fatty acid levelsGCST905027269.28
1398FIS1/HSPA1A ratioGCST903148259.26
1399Waking up during the night and not easily going back to sleepGCST904763869.25
1400Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107ECGU0001079.24
1401Phospholipids in very large VLDL (UKB data field 23490)GCST902695879.24
1402ERBIN levelsGCST904691429.23
1403Cholesterol in very large VLDL (UKB data field 23491)GCST902695889.22
1404Left hippocampal volumeGCST902679529.22
1405Saturated fatty acids levelsGCST905026709.20
1406wg rh intensity-contrast temporalpoleGCST900038599.20
1407Ascending aorta diameterGCST902673909.20
1408Concentration of large VLDL particles (UKB data field 23495)GCST902695929.19
1409SIRT2 levelsGCST904706429.19
1410Obstructive chronic bronchitis (PheCode 496.21)GCST904760309.18
1411Feeling worryGCST0069509.16
1412Total lipids in large VLDLGCST904982079.16
1413CANT1/VSIR ratioGCST903136219.16
1414Omega-6 fatty acid levelsGCST905021019.16
1415PALM levelsGCST904701549.16
1416DTI TBSS L3 Cingulum hippocampus RGCST903845609.15
1417CELA3A levelsGCST904687029.13
1418CKAP4/PGF ratioGCST903140759.13
1419CRTAM/PDCD1 ratioGCST903142799.12
1420Cholesteryl Esters in Small LDLGCST904995869.12
1421MSRA/P4HB ratioGCST903154959.12
1422CDCP1 levelsGCST904686679.11
1423AmygNuclei lh volume Lateral-nucleusGCST900026489.11
1424STAT5B levelsGCST904707599.11
1425Triglyceride levels in small VLDLGCST901326679.11
1426FXYD5 levelsGCST904692839.10
1427IL17A levelsGCST904695589.09
1428Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDLGCST900930439.09
1429GM3 ganglioside (d18:1/24:0) levelsGCST900253409.08
1430CLIP2/LAT2 ratioGCST903141289.08
1431Carnitine levelsGCST902434819.07
1432T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST903206849.06
1433CALB1 levelsGCST904685269.06
1434CD46/SELP ratioGCST903138349.05
1435Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136ECGA0001369.03
1436EFEMP1/TGFBR3 ratioGCST903145979.02
1437Free cholesterol in very large VLDL (UKB data field 23493)GCST902695909.01
1438Principal component-derived dietary pattern 31GCST901330369.01
1439CNPY4 levelsGCST904688009.00
1440CRELD2/NUCB2 ratioGCST903142568.99
1441Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900251158.98
1442Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T174ECGA0001748.98
1443Phospholipids to total lipids ratio in very large VLDLGCST900930258.97
1444BSG/CKAP4 ratioGCST903135318.97
1445Free cholesterol in small LDLGCST904996208.96
1446MET levelsGCST904698958.95
1447Phospholipids in small LDLGCST904996818.94
1448TNFAIP8 levelsGCST904708988.94
1449FADD/GRAP2 ratioGCST903147668.93
1450CELA2A levelsGCST904687018.91
1451IDP dMRI TBSS MD Sagittal stratum LGCST900040588.91
1452rfMRI connectivity (ICA100 edge 495)GCST900053488.91
1453Triacylglycerol_46:4_[M+NH4]1+ levelsGCST900603628.91
1454IL18BP/THBD ratioGCST903151568.91
1455GGCT levelsGCST904693348.89
1456Cereal type - Other (e.g. Cornflakes, Frosties) | DietUKBB000001258.88
1457LRTM2 levelsGCST904698088.88
1458IDP dMRI TBSS ICVF External capsule RGCST900043598.87
1459Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54ECGA0000548.87
1460Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697368.87
1461CD58/ERBB3 ratioGCST903138488.87
1462Monounsaturated fatty acids to total fatty acids percentageGCST905020498.87
1463Total lipid levels in chylomicrons and extremely large VLDLGCST900930468.87
1464Cholesterol to total lipids in medium LDL percentage (UKB data field 23620)GCST902697178.85
1465Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25ECGA0000258.85
1466Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992888.85
1467CCL14/CST3 ratioGCST903136798.85
1468DKK1/SDC4 ratioGCST903144798.84
1469Triacylglycerol_52:3_[M+NH4]1+ levelsGCST900605098.84
1470Triglyceride levels in small LDLGCST900929668.83
1471GRAP2/LACTB2 ratioGCST903149808.83
1472CDH5/PEAR1 ratioGCST903139598.83
1473Immature fraction of reticulocytesGCST900023878.83
1474Concentration of very large VLDL particlesGCST905006288.83
1475Plasma 1-arachidonoyl-GPE (20:4n6)* levels in chronic kidney diseaseGCST902642078.82
1476ENG/NCAM2 ratioGCST903146478.82
1477Free cholesterol in large LDLGCST904979878.82
1478Cholesterol in small VLDL (UKB data field 23512)GCST902696098.82
1479FGF19/SCG2 ratioGCST903148098.82
1480Lung volumeGCST900166688.81
1481IDP dMRI TBSS L2 Superior cerebellar peduncle RGCST900041358.81
1482CST3/TFF3 ratioGCST903142998.80
1483CD58/MCAM ratioGCST903138528.80
1484Omega-3 fatty acids to total fatty acids percentageGCST905024628.79
1485ATXN10/SLC27A4 ratioGCST903133998.78
1486ANGPT1/DKK1 ratioGCST903132638.77
1487Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009758.77
1488Fasting insulinGCST900022388.76
1489Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST903181088.75
1490Operative procedures - Total cholecystectomy NEC | Summary OperationsUKBB000005898.75
1491DTI autoptx L1 ptr r tractGCST903851598.75
1492Triglycerides in LDLGCST904984698.74
1493OXCT1 levelsGCST904701388.74
1494VLDL cholesterol levelsGCST905001898.74
1495Conditional arithmetic | Fluid intelligence / reasoningUKBB000001458.72
1496Triglycerides to Total Lipids in Small LDL percentageGCST904997268.72
1497Cheese consumptionGCST901330008.72
1498Cholesteryl esters to total lipids ratio in large LDLGCST900928598.72
1499Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T14ECGA0000148.72
1500SEMA4D levelsGCST904705738.72
1501ESAM levelsGCST904691528.71
1502Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010508.71
1503Triacylglycerol_52:6_[M+NH4]1+ levelsGCST900605048.70
1504PILRA/TNFRSF1A ratioGCST903156558.69
1505WASHC3 levelsGCST904710698.68
1506FURIN/IGSF3 ratioGCST903148858.68
1507BACH1/DIABLO ratioGCST903134378.67
1508Haemorrhoidal diseaseGCST900140338.67
1509Lung cancerGCST900118128.66
1510Cholesteryl esters in very large HDL (UKB data field 23555)GCST902696528.66
1511Cholesterol, totalGCST0022218.65
1512Total lipids in very small VLDL (UKB data field 23517)GCST902696148.65
1513Mean corpuscular haemoglobin concentration (UKB data field 30060)GCST904680858.65
1514HMCN2 levelsGCST904694618.65
1515HYOU1/ROR1 ratioGCST903151048.64
1516CSF1/SEMA3F ratioGCST903142888.63
1517Triglyceride levels in chylomicrons and extremely large VLDLGCST905010688.63
1518TNFSF12/TNFSF13 ratioGCST903159418.62
1519APOC1 levelsGCST904683368.62
1520CD59/SCARB2 ratioGCST903138598.60
1521Alcohol intake versus 10 years previously | AlcoholUKBB000000248.60
1522IDP dMRI TBSS MD Corticospinal tract RGCST900040338.60
1523CLSTN2/MATN2 ratioGCST903141438.59
1524Monounsaturated fatty acid levelsGCST905023588.59
1525FCN1 levelsGCST906185658.59
1526Shoulder lesionsFING000013038.59
1527Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108ECGU0001088.58
1528ALB levelsGCST904751068.58
1529METAP2/PLPBP ratioGCST903154328.58
1530AMBP/ASGR1 ratioGCST903132518.57
1531Cholesterol in very large HDL (UKB data field 23554)GCST902696518.57
1532Sphingomyelin_41:2_[M+H]1+ levelsGCST900603838.57
1533CDKN1A/TXLNA ratioGCST903139798.57
1534Concentration of very large VLDL particles (UKB data field 23488)GCST902695858.57
1535APP/CD40LG ratioGCST903133198.55
1536CD33 levelsGCST904686258.55
1537Sphingomyelin (d18:1/16:0) levelsGCST900257448.55
1538IDP dMRI TBSS ICVF Superior longitudinal fasciculus LGCST900043688.54
1539ICD10 C53: Malignant neoplasm of cervix uteriGCST904542028.54
1540MERTK levelsGCST904698908.53
1541BACH1/CNST ratioGCST903134368.52
1542Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levelsGCST902001038.52
1543APRT/EREG ratioGCST903133358.52
1544ENO1 levelsGCST904691098.52
1545Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009838.51
1546Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T253ECGU0002538.50
1547Osteomyelitis (PheCode 710.1)GCST904762218.50
1548Pure hypercholesterolaemiaFING000012308.49
1549CD99/RELT ratioGCST903139308.49
1550Total lipids in small HDLGCST904994438.49
1551CD93 levelsGCST904686568.49
1552TriglyceridesGCST0007588.49
1553CA1/TGM2 ratioGCST903135758.48
1554ESAM/JAM2 ratioGCST903147128.48
1555Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T414ECGU0004148.47
1556Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T90ECGU0000908.47
1557Phlebitis and thrombophlebitis (not including DVT)FING000011658.47
1558ACVRL1 levelsGCST904682118.47
1559Cholesteryl ester levels in HDLGCST900928238.45
1560ERBB3 levelsGCST904691408.45
1561aseg global intensity 4th-VentricleGCST900037528.43
1562Concentration of very small VLDL particles (UKB data field 23516)GCST902696138.43
1563IDP dMRI ProbtrackX MD cgc lGCST900042238.41
1564Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T255ECGA0002558.41
1565Cholesterol to total lipids ratio in medium LDLGCST900929058.41
1566Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST900930428.40
1567Free Cholesterol to Total Lipids in Small LDL percentageGCST904996378.40
1568KITLG/PLTP ratioGCST903152528.40
1569Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T377ECGA0003778.38
1570CEACAM19 levelsGCST904686918.38
1571Concentration of small LDL particles (UKB data field 23544)GCST902696418.38
1572Familial combined hyperlipidemia defined by Mexico criteriaGCST901040078.37
1573CEP112 levelsGCST904687088.37
1574Phospholipids in large VLDL (UKB data field 23497)GCST902695948.37
1575ALB levelsGCST904751038.36
1576Spread type: Butter and margarine vs never use spread (UKB data field 1428)GCST901329488.34
1577mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754548.34
1578LDL cholesterolGCST0007598.32
1579CRADD/FADD ratioGCST903142378.32
1580Asthma mixed form (mode) (more control exclusions)FING000001168.32
1581IDP dMRI TBSS FA Cerebral peduncle RGCST900038918.31
1582SCARA5/TGFBI ratioGCST903158098.31
1583PRND levelsGCST904703338.30
1584SLITRK6 levelsGCST904706718.30
1585METAP2/USP8 ratioGCST903154348.30
1586Saturated fatty acids levelsGCST905021858.30
1587Triglycerides to Total Lipids in Medium LDL percentageGCST904988818.30
1588ADH4/SORD ratioGCST903131968.30
1589Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426788.29
1590ICD10 E28.2: Polycystic ovarian syndromeGCST904542058.29
1591ADGRE2/CD58 ratioGCST903131758.28
1592Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109ECGU0001098.28
1593FIS1 levelsGCST904692408.26
1594rfMRI amplitudes (ICA25 node 14)GCST900045818.26
1595CDKN1A/PLA2G4A ratioGCST903139748.26
1596Autoimmune hepatitisGCST900185658.26
1597DCBLD2/PLA2G15 ratioGCST903144288.25
1598CLK2 levelsGCST902409758.25
1599Phospholipids in small HDL (UKB data field 23574)GCST902696718.25
1600Cholesterol to Total Lipids in Small VLDL percentageGCST904997608.25
1601Total cholines levels (UKB data field 23436)GCST902695338.23
1602IDP dMRI TBSS MD Cingulum hippocampus RGCST900040638.23
1603NIT2 levelsGCST904700518.23
1604Sphingomyelin_34:2_[M+H]1+ levelsGCST900602358.22
1605Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992878.21
1606Phosphatidylcholine diacyl C36:4 levelsGCST902400408.21
1607DCTN1/TRIAP1 ratioGCST903144348.21
1608KAZALD1 levelsGCST904696658.20
1609Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004208.20
1610PLA2G4A/PPP1R12A ratioGCST903156668.20
1611Hypertrophy of breast in women and menFING000006458.20
1612Left ventricular end diastole anterospetal wall thicknessGCST902785198.20
1613Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T95ECGU0000958.19
1614PMVK levelsGCST904702728.17
1615QC rfMRI cleaned inverse tSNRGCST900063588.15
1616Concentration of small VLDL particlesGCST904998688.15
1617GALNT3 levelsGCST904692978.15
1618rfMRI amplitudes (ICA100 node 2)GCST900045908.14
1619ARHGEF12/IRAK4 ratioGCST903133508.14
1620Total cholesterol levels in medium VLDLGCST901326898.14
1621Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009568.14
1622AMOTL2 levelsGCST904682948.13
1623LRP11/NECTIN2 ratioGCST903153298.13
1624IDP dMRI TBSS L1 Corticospinal tract RGCST900040818.13
1625LPCAT2 levelsGCST902418418.13
1626Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levelsGCST900602808.13
1627DTI TBSS L3 Superior corona radiata LGCST903845498.13
1628Phosphatidylcholine (40:8) levelsGCST900242998.12
1629CLPS/CTRB1 ratioGCST903141398.12
1630Cholesteryl esters to total lipids in small LDL percentage (UKB data field 23626)GCST902697238.11
1631Cholesteryl ester (16:2) levelsGCST900252388.10
1632SPOCK2 levelsGCST902429878.10
1633Total lipids in large VLDL (UKB data field 23496)GCST902695938.09
1634Tetradecadienedioate (C14:2-DC) metabolite levelGCST906162758.09
1635DTI TBSS MD Cingulum hippocampus RGCST903846088.08
1636Free cholesterol in large VLDL (UKB data field 23500)GCST902695978.08
1637BA-exvivo rh area BA3aGCST900032238.08
1638Benign neoplasm of eye, uveal (PheCode 224.1)GCST904756298.07
1639Hemoglobin concentration varianceGCST905656858.06
1640Phosphatidylcholine (14:0_22:6) levelsGCST900242348.06
1641Triglyceride levels in very large HDLGCST901326368.05
1642Triglyceride levels in medium HDLGCST900929028.05
1643DTI autoptx MD ptr l tractGCST903852398.04
1644APOH levelsGCST904683408.04
1645ENO2/PRSS27 ratioGCST903146668.03
1646IDP dMRI TBSS L3 Superior cerebellar peduncle RGCST900041838.03
1647FLT1/VEGFA ratioGCST903148588.02
1648Phospholipids to Total Lipids in Small VLDL percentageGCST904998958.02
1649Familial combined hyperlipidemia defined by Brunzell criteriaGCST901040038.02
1650High density lipoprotein cholesterol levelsGCST902396518.02
1651CASP1 levelsGCST904685438.02
1652Phospholipid levels in chylomicrons and extremely large VLDLGCST900930488.02
1653Total testosterone levelsGCST900121148.02
1654LUZP2 levelsGCST904698198.01
1655GFRAL levelsGCST904693318.01
1656CASP3/LYN ratioGCST903136358.01
1657Triglycerides to Total Lipids in Medium VLDL percentageGCST904990738.00
1658Phospholipids in small VLDL (UKB data field 23511)GCST902696087.99
1659Triglyceride levels in small HDLGCST900929547.97
1660Concentration of VLDL particlesGCST905002507.97
1661Total cholesterol levelsGCST905000227.95
1662Omega-3 fatty acids to total fatty acids percentageGCST905024637.94
1663Main speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB000004167.93
1664Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376ECGA0003767.92
1665Saturated fatty acids levelsGCST905026717.92
1666TEK levelsGCST904708297.90
1667TNFRSF11A levelsGCST904709027.90
1668ADGRG2/ITGB1 ratioGCST903131857.90
1669Diabetic retinopathy (PheCode 250.7)GCST904756897.89
1670LBR/POLR2F ratioGCST903152977.89
1671Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST902697397.89
1672L1CAM levelsGCST904697237.87
1673APOA4 levelsGCST904683337.87
1674low density lipoprotein cholesterol (LDLC, minimum, inv-norm transformed)GCST904754207.87
1675BCAM/EPO ratioGCST903134717.85
1676Concentration of chylomicrons and extremely large VLDL particlesGCST900930477.85
1677CD69/SNAP23 ratioGCST903138867.85
1678IL27 levelsGCST900120177.85
1679TRIAP1 levelsGCST904709637.84
1680DNAJB1/SIRT2 ratioGCST903145117.84
1681Salad leaves likingGCST900948237.82
1682NUB1 levelsGCST904700997.82
1683IL6R levelsGCST904696027.81
1684FLRT2 levelsGCST904692487.81
1685Triglycerides in very large HDLGCST905004817.81
1686Allergic rhinitisGCST900860427.81
1687DCN levelsGCST904689567.80
1688BLVRB/HMBS ratioGCST903135267.78
1689FLT4/ICAM2 ratioGCST903148607.78
1690BIN1 levelsGCST900907577.78
1691AmygNuclei lh volume Whole-amygdalaGCST900026577.78
1692CHGB levelsGCST904687427.77
1693Ankylosing spondylitis, strict definitionFING000000907.77
1694TMEM106A levelsGCST904708867.77
1695Lysoalkylphosphatidylcholine (O-24:2) levelsGCST900254387.76
1696Triglyceride levels in very large HDLGCST900930147.76
1697CABP2 levelsGCST904685197.75
1698Cholesterol levels in chylomicrons and extremely large VLDLGCST900930407.75
1699LHPP levelsGCST904697687.75
1700PCSK9 levelsGCST904701777.74
1701ThalamNuclei rh volume CeMGCST900027517.74
1702FLT1/TFPI2 ratioGCST903148567.72
1703AGRP levelsGCST904682567.72
1704CirrhosisGCST903198777.72
1705SLC35G2 levelsGCST902428577.72
1706Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T256ECGA0002567.71
1707IDP dMRI TBSS MO FornixGCST900039577.71
1708SDC4/SELP ratioGCST903158177.70
1709IDP dMRI TBSS ICVF Body of corpus callosumGCST900043307.69
1710Cholesteryl ester_18:2_[M+NH4]1+ levelsGCST900602207.69
1711Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST904762587.69
1712B3GNT7 levelsGCST904684117.68
1713aparc-Desikan rh area fusiformGCST900031137.67
1714Total testosterone levelsGCST900121127.66
1715Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009587.66
1716Sphingomyelin_38:1_[M+H]1+ levelsGCST900603067.66
1717Biological Sibling: Alzheimer's / Other DementiaGCST904763757.66
1718COMP/TGFBI ratioGCST903141927.65
1719FKBP4/FKBP5 ratioGCST903148387.65
1720C3 levelsGCST904684987.64
1721Total lipids in small VLDL (UKB data field 23510)GCST902696077.64
1722Total fatty acid levelsGCST905027227.64
1723Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T175ECGA0001757.64
1724CD99/KITLG ratioGCST903139247.64
1725Cholesteryl esters in medium LDL (UKB data field 23541)GCST902696387.63
1726AmygNuclei rh volume Basal-nucleusGCST900026597.62
1727F12 levelsGCST904691667.62
1728Insomnia (weighted GWA)GCST902672877.61
1729Cholesteryl ester levels in very large VLDLGCST900930187.61
1730Triglyceride levels in small VLDLGCST900929787.61
1731Phospholipids to Total Lipids in Large VLDL percentageGCST904982587.60
1732Cholesterol to total lipids in medium HDL percentage (UKB data field 23640)GCST902697377.59
1733Triglycerides in LDLGCST904984727.59
1734Sphingomyelin_42:3_[M+H]1+ levelsGCST900603997.59
1735IDP dMRI TBSS FA Posterior limb of internal capsule RGCST900038957.59
1736Total triglycerides levelsGCST905001407.58
1737APOB/APOA1 ratioGCST900928107.58
1738Triglycerides x low social support interaction (2df test)GCST905706817.57
1739LBR/PSRC1 ratioGCST903153007.57
1740EGFR levelsGCST904690857.57
1741COL6A3/HSPG2 ratioGCST903141757.57
1742Triglycerides to total lipids in very large HDL percentage (UKB data field 23633)GCST902697307.57
1743INPP1 levelsGCST904696167.56
1744DCBLD2 levelsGCST904689527.56
1745Total lipids in small LDL (UKB data field 23545)GCST902696427.55
1746CAG-177 sp003538135 abundance in stoolGCST900322607.55
1747CASP10/PRTFDC1 ratioGCST903136277.53
1748Triacylglycerol_50:5_[M+NH4]1+ levelsGCST900604637.53
1749Free cholesterol to total lipids in large HDL percentage (UKB data field 23637)GCST902697347.53
1750Cholesterol levels in small VLDLGCST900929687.52
1751Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987847.52
1752AMY2B levelsGCST904682997.51
1753LGALS8 levelsGCST904697647.51
1754Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403ECGU0004037.50
1755Treatment/medication code - paracetamol | MedicationsUKBB000008537.50
1756Operation code - wisdom teeth surgery | OperationsUKBB000005697.50
1757aparc-a2009s lh area S-temporal-supGCST900033697.50
1758Free cholesterol in very large HDL (UKB data field 23556)GCST902696537.50
1759ADGRE5/NOTCH1 ratioGCST903131817.50
1760Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378ECGA0003787.49
1761Triglyceride to HDL cholesterol ratioGCST902959507.49
1762Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T106ECGU0001067.48
1763Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025677.48
1764CALCOCO1/IRAG2 ratioGCST903136047.48
1765Concentration of large VLDL particlesGCST904982267.48
1766NPTXR levelsGCST904700807.47
1767Citrate levelsGCST904972007.47
1768Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405ECGU0004057.47
1769IDP dMRI TBSS L2 FornixGCST900041287.47
1770Red wine consumption (glasses per month) (UKB data field 1578, 4419)GCST901329877.46
1771Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARBUKBB000006627.46
1772CDHR5 levelsGCST904686807.46
1773Burger likingGCST900947157.46
1774Autorefraction - 3mm cylindrical power (right) | EyesightUKBB000000637.44
1775ADAM15 levelsGCST904682177.44
1776IDP dMRI TBSS ICVF Superior cerebellar peduncle LGCST900043407.44
1777ECM1 levelsGCST904690657.44
1778Triglyceride levels in HDLGCST900928297.44
1779Triglycerides x depression interaction (2df test)GCST905706797.44
1780CPA1/CPB1 ratioGCST903142027.44
1781Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T107ECGA0001077.43
1782Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009207.43
1783End-diastolic bi-ventricular shape (principal component 2)GCST904484817.42
1784ANXA4/HSPB1 ratioGCST903132927.42
1785Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T379ECGA0003797.41
1786Nervous feelings | Mental healthUKBB000004957.41
1787LEP levelsGCST0033687.40
1788Red cell distribution widthGCST0046217.40
1789Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643287.40
1790MZT1 levelsGCST904699887.40
1791aparc-a2009s lh thickness G-postcentralGCST900036307.40
1792Ribothymidine levels in chronic kidney diseaseGCST902575547.40
1793Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006557.39
1794PPT1 levelsGCST904277187.39
1795rfMRI connectivity (ICA100 edge 912)GCST900057657.37
1796GLOD4/MIF ratioGCST903149397.37
1797ITM2A levelsGCST904696537.37
1798Cholesteryl ester (16:2) levelsGCST900246287.36
1799Triglycerides to total lipids ratio in large HDLGCST900928557.36
1800Total cholines levelsGCST900928127.36
1801Monounsaturated fatty acids to total fatty acids percentageGCST905020437.35
1802Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T340ECGA0003407.35
1803Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8ECGA0000087.35
1804Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989447.33
18051,5-anhydroglucitol (1,5-ag) levelsGCST902435297.33
1806Triglycerides to Total Lipids in Small LDL percentageGCST904997407.33
1807EREG levelsGCST904691457.32
1808Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005987.32
1809CIAPIN1 levelsGCST904687537.32
1810aparc-a2009s rh area Pole-occipitalGCST900034127.31
1811COL9A1 levelsGCST904688227.31
1812Spread type - Never/rarely use spread | DietUKBB000007947.30
1813Free cholesterol in small HDLGCST904994117.30
1814SUSD2 levelsGCST904707877.29
1815Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176ECGU0001767.29
1816GLOD4 levelsGCST904693597.28
1817IDP dMRI ProbtrackX L3 cgc lGCST900043047.28
1818Free Cholesterol in LDLGCST904983887.28
1819Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375ECGA0003757.28
1820ANGPTL7 levelsGCST904683067.27
1821CPM levelsGCST902405987.26
1822Triglycerides | Blood biochemistryUKBB000008617.26
1823CTSF/CTSV ratioGCST903143137.26
1824S100P levelsGCST904705207.26
1825BA-exvivo rh volume BA3aGCST900028517.26
1826CD99L2 levelsGCST904686577.25
1827Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivityGCST903027597.25
1828Triglycerides to Total Lipids in IDL percentageGCST904976827.24
1829Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025707.23
1830Omega-6 fatty acids to total fatty acids percentageGCST905025457.22
1831Angina pectoris | Ischaemic heart diseasesUKBB000000317.22
1832HSD11B1 levelsGCST904694827.22
1833LDLR/PCSK9 ratioGCST903153117.21
1834Concentration of VLDL particles (UKB data field 23428)GCST902695257.21
1835Alcohol frequency weekly (standard GWA)GCST902672667.21
1836Colon cancerGCST900118117.20
1837Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T28ECGA0000287.19
1838F-healthy food liking (derived food-liking factor)GCST900947797.19
1839CD58/IL10RB ratioGCST903138507.19
1840Linoleic acid levelsGCST905023077.18
1841CDKN1A/TMSB10 ratioGCST903139787.18
1842aparc-DKTatlas lh thickness paracentralGCST900035557.18
1843FGA levelsGCST904692167.18
1844ADGRE5/GAS6 ratioGCST903131797.18
1845IDP dMRI TBSS MO Posterior corona radiata RGCST900039787.18
1846Red cell distribution widthGCST900023697.17
1847IDP dMRI TBSS ICVF Inferior cerebellar peduncle LGCST900043387.17
1848Monounsaturated fatty acids to total fatty acids percentageGCST905023887.17
1849FNDC1 levelsGCST904692567.17
1850CRKL/SERPINB1 ratioGCST903142727.16
1851Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T109ECGA0001097.16
1852Osteoporosis (PheCode 743.1)GCST904763847.16
1853ALB levelsGCST902786167.15
1854Free Cholesterol to Total Lipids in Large VLDL percentageGCST904981997.15
1855MIF/SUSD2 ratioGCST903154527.15
1856SERPING1 levelsGCST904706007.14
1857WorryGCST0064787.14
1858NCK2/VASH1 ratioGCST903155267.13
1859High light scatter reticulocyte percentage of red cellsGCST0046127.13
1860Cholesteryl ester levels in medium LDLGCST900929067.12
1861Other aneurysm (PheCode 442)GCST904759927.12
1862T1 FreeSurfer DK rh supramarginal volumeGCST903857877.12
1863Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246ECGU0002467.11
1864CD244/GP1BA ratioGCST903137667.11
1865AXIN1/SRPK2 ratioGCST903134177.11
1866IDP dMRI TBSS L2 Inferior cerebellar peduncle RGCST900041337.10
1867ESM1 levelsGCST904691537.09
1868Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T339ECGA0003397.09
1869NXPH3 levelsGCST904701127.09
1870SERPIND1 levelsGCST904705957.09
1871ICAM1 levelsGCST904694987.09
1872HAVCR2 levelsGCST904694327.09
1873ITPR1 levelsGCST904696557.07
1874NAGK levelsGCST904699957.06
1875Treatment or medication use - atorvastatin (UKB data field 20003_1141146234)GCST900423767.06
1876B4GALT1/IFNGR1 ratioGCST903134307.06
1877Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis?GCST904752737.05
1878Saturated fatty acid levelsGCST900929807.05
1879Ceramide_40:1_[M-H]1- levelsGCST900601987.04
1880PTP4A3 levelsGCST904703757.04
1881Platelet countGCST0046037.04
1882Hepatomegaly (PheCode 573.3)GCST904760927.04
1883VCAN levelsGCST904710327.02
1884Neutrophil countGCST900023527.01
1885IL6ST/MARCO ratioGCST903151677.01
1886DCXR/GSTA1 ratioGCST903144377.00
1887Phospholipids in VLDL (UKB data field 23412)GCST902695096.99
1888Free Cholesterol to Total Lipids in IDL percentageGCST904975796.99
1889Monounsaturated fatty acid levelsGCST900929286.98
1890Triglycerides in medium VLDL (UKB data field 23508)GCST902696056.98
1891Free cholesterol in small VLDL (UKB data field 23514)GCST902696116.98
1892CPM/PCSK9 ratioGCST903142166.98
1893FKBP5/ZBTB16 ratioGCST903148506.97
1894NRCAM/PCDH17 ratioGCST903155536.97
1895Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T380ECGA0003806.97
18961-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levelsGCST901996496.96
1897IDP dMRI TBSS L3 Superior cerebellar peduncle LGCST900041846.96
1898DBNL/DNAJA2 ratioGCST903144156.96
1899Monounsaturated fatty acid levelsGCST905020306.95
1900Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T348ECGA0003486.95
1901PTGES2 levelsGCST904703696.94
1902Triacylglycerol_56:4_[M+NH4]1+ levelsGCST900605566.94
1903DTI autoptx L2 ptr r tractGCST903851866.94
1904IDP dMRI TBSS ICVF Anterior limb of internal capsule LGCST900043446.94
1905Plasma N-acetyltaurine levels in chronic kidney diseaseGCST902656006.93
1906Cholesteryl esters to total lipids ratio in medium LDLGCST900929076.93
1907ATG4A/NSFL1C ratioGCST903133686.93
1908T1 FreeSurfer DKT rh supramarginal volumeGCST903843776.92
1909RNF43 levelsGCST904224826.91
1910ALCAM levelsGCST904682796.90
1911Triglycerides to total lipids ratio in very large HDLGCST900930156.90
1912CLEC11A levelsGCST904687646.89
1913ADM/CLMP ratioGCST903131976.89
1914Concentration of small VLDL particles (UKB data field 23509)GCST902696066.89
1915Free cholesterol to total lipids ratio in very small VLDLGCST900930336.89
1916Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005396.89
1917MAD1L1 levelsGCST904698366.89
1918Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T399ECGU0003996.88
1919Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007916.88
1920Total Phosphatidylethanolamine levelsGCST900252076.87
1921CD209/CLEC4G ratioGCST903137506.87
1922Parental longevity (mother's attained age)GCST0066966.87
1923PLXNA4/SUSD1 ratioGCST903156896.87
1924Cholesteryl Esters in Small LDLGCST904995786.87
1925N6,N6-dimethyllysine levels in chronic kidney diseaseGCST902575296.86
1926CPA2/ITGB7 ratioGCST903142076.86
1927Offspring birth weightGCST0053146.86
1928Triglycerides to Total Lipids in Small HDL percentageGCST904995306.86
1929triglyceride (maximum, inv-norm transformed)GCST904764316.86
1930Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T89ECGU0000896.86
1931SNX5 levelsGCST904707026.86
1932Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025556.85
1933CD40LG/TRAF2 ratioGCST903138286.85
1934Concentration of large LDL particles (UKB data field 23530)GCST902696276.85
1935Total lipids in small VLDLGCST904998496.85
1936Mean corpuscular hemoglobin concentrationGCST900023286.84
1937MET/PTPRF ratioGCST903154356.84
1938In your lifetime, have you smoked a total of at least 100 cigarettes?GCST904763876.84
1939Alkenylphosphatidylcholine (P-36:3) levelsGCST900249546.84
1940Total fatty acid levelsGCST905027116.84
1941Sphingomyelin_40:2_[M+H]1+ levelsGCST900603526.83
1942DECR1/STX8 ratioGCST903144526.83
1943PCSK9 levelsGCST904281106.83
1944aseg global volume CC-CentralGCST900026096.83
1945Type 2 diabetes with ophthalmic manifestations (PheCode 250.23)GCST904756736.83
1946Cholesteryl Esters in VLDLGCST905002056.82
19474-hydroxyglutamate levelsGCST901998906.82
1948Ever felt worried, tense, or anxious for most of a month or longer | AnxietyUKBB000002156.82
1949Total concentration of lipoprotein particles (UKB data field 23427)GCST902695246.80
1950MCFD2/VSIR ratioGCST903154116.80
1951CCL21 levelsGCST904685736.80
1952Feeling fed-upGCST0069476.79
1953Cholesteryl esters in small LDL (UKB data field 23548)GCST902696456.79
1954Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005696.79
1955Alkaline phosphatase (UKB data field 30610)GCST904680606.79
1956Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605536.79
1957IDP dMRI TBSS L1 External capsule RGCST900041076.79
1958Phospholipids to Total Lipids in Large LDL percentageGCST904980586.79
1959Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005426.78
1960IDP dMRI TBSS ISOVF Cingulum cingulate gyrus RGCST900045116.77
1961Familial combined hyperlipidemia defined by Consensus criteriaGCST901040066.77
1962SEZ6L2 levelsGCST904706066.77
1963P4HB levelsGCST904701406.76
1964IGF1R levelsGCST904695246.76
1965GABARAPL1 levelsGCST904692876.75
1966DTI TBSS L2 Superior fronto-occipital fasciculus RGCST903845186.75
1967Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358ECGA0003586.74
1968aparc-DKTatlas rh area fusiformGCST900032706.74
1969LifespanGCST905518856.73
1970Polyunsaturated fatty acid levelsGCST905021346.73
1971C4 levelsGCST902810426.73
1972Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170ECGA0001706.73
1973CD200R1/CLEC4G ratioGCST903137486.73
1974T1 FreeSurfer DK lh superiortemporal thicknessGCST903856516.72
1975Free cholesterol in very small VLDL (UKB data field 23521)GCST902696186.72
1976SFRP2 levelsGCST902427276.72
1977APOM/ERBB3 ratioGCST903133146.72
1978Free Cholesterol to Total Lipids in Large LDL percentageGCST904980076.71
1979Triglycerides in very large HDLGCST905004826.71
1980ICD10 N86: Erosion and ectropion of cervix uteriGCST904542176.71
1981IDP dMRI TBSS L3 Inferior cerebellar peduncle LGCST900041826.71
1982BTC levelsGCST904684766.70
1983BSG levelsGCST904684726.70
1984Total lipids in VLDL (UKB data field 23424)GCST902695216.69
1985Phospholipids in very large VLDLGCST905006446.69
1986IGBP1 levelsGCST904695216.69
1987Other localized connective tissue disordersFING000010666.68
1988Triacylglycerol_52:4_[M+NH4]1+ levelsGCST900605086.68
1989Phosphatidylcholine_40:6_[M+H]1+/Phosphatidylethanolamine_43:6_[M+H]1+ levelsGCST900604466.68
1990LPL levelsGCST904697886.68
1991DTI TBSS L2 Superior longitudinal fasciculus LGCST903845176.67
1992CTSZ/NAAA ratioGCST903143206.66
1993Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T12ECGA0000126.65
1994Triglyceride levels in VLDLGCST900930036.65
1995Other diseases of blood and blood-forming organsFING000009986.64
1996CALCOCO1/INPPL1 ratioGCST903136036.64
1997Total fatty acid levelsGCST905022126.63
1998Treatment speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB000008326.63
1999Sleep apnea (MTAG) (adjusted for BMI)GCST902673646.62
2000DTI TBSS MD Anterior corona radiata RGCST903845946.62